Lombard Odier & Cie (Canada)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$1.05M Buy
16,600
+600
+4% +$38.8K 2.98% 12
2016
Q2
$990K Sell
16,000
-6,900
-30% -$420K 3.46% 9
2016
Q1
$1.31M Sell
22,900
-1,200
-5% -$66.9K 3.48% 11
2015
Q4
$1.43M Buy
24,100
+9,800
+69% +$564K 3.67% 8
2015
Q3
$778K Buy
14,300
+1,050
+8% +$68.3K 2.08% 19
2015
Q2
$890K Sell
13,250
-1,150
-8% -$75.1K 1.93% 22
2015
Q1
$842K Buy
+14,400
New +$870K 1.32% 27

Other funds holding ABBV

Lombard Odier & Cie (Canada)'s ABBV Position: Q3 2016 in Review

Lombard Odier & Cie (Canada) increased its AbbVie (ABBV) stake by 3.8% in Q3 2016, buying an estimated $38.8K and bringing the position to 16,600 shares worth $1.05M. The position accounts for 2.98% of the portfolio, ranked #12.

Lombard Odier & Cie (Canada) first reported a position in ABBV in Q1 2015 and has held it in 7 quarters since. The position peaked at $1.43M in Q4 2015. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Lombard Odier & Cie (Canada) held 16,600 shares of AbbVie worth $1.05M as of Q3 2016.
  • Lombard Odier & Cie (Canada) bought 600 AbbVie shares in Q3 2016, an estimated $38.8K.
  • AbbVie made up 2.98% of Lombard Odier & Cie (Canada)'s portfolio in Q3 2016, its #12 holding.
  • Lombard Odier & Cie (Canada) first reported a position in AbbVie in Q1 2015 and has held it in 7 quarters since.
  • Lombard Odier & Cie (Canada)'s AbbVie position peaked at $1.43M in Q4 2015.
  • 1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Lombard Odier & Cie (Canada)'s 13F filing for Q3 2016, filed 14 Nov 2016.